Home   >  
Angiogenesis/Protein Tyrosine Kinase
Ephrin Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

Ephrin Receptor

Chemical Structure Cat. No. Product Name CAS No.
123C4 Chemical Structure
BCP44969 123C4 2034159-30-1
123C4 is a novel, potent, and selective agonist of the tyrosine kinase EphA4 receptor.
NVP-BHG712 isomer Chemical Structure
BCP43510 NVP-BHG712 isomer 2245892-85-5
NVP-BHG712 isomer, a regioisomer of NVP-BHG712, shows conserved non-bonded binding to EPHA2 and EPHB4.
JI-101 Chemical Structure
BCP16892 JI-101 900573-88-8
JI-101 is a n orally active inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor beta (PDGFRb), and the ephrin B4 receptor B4 (EphB4) with potential antiangiogenic and antineoplastic activities.
NVP-BHG712 Chemical Structure
BCP02362 NVP-BHG712 940310-85-0
NVP-BHG712 is a small molecule specific EphB4, VEGFR2, c-raf, c-src and c-Abl kinase inhibitor with ED50 of 25 nM, 4.2, 0.4, 1.3 and 1.7μM, respectively.
Tesevatinib Chemical Structure
BCP23438 Tesevatinib 781613-23-8
XL-647 (Tesevatinib, EXEL-7647, KD-019) is a novel spectrum-selective kinase inhibitor that potently inhibits the EGFR, ErbB2, KDR and EphB4 with IC50 of 0.3, 16, 1.5 and 1.4 nM, respectively.
XL647(Racemate) Chemical Structure
BCP02839 XL647(Racemate) 874286-84-7
XL-647 (Tesevatinib;XL-647;KD-019) is an orally available, multi-target tyrosine kinase inhibitor; inhibits EGFR, ErbB2, KDR, Flt4 and EphB4 kinase with IC50s of 0.3, 16, 1.5, 8.7, and 1.4 nM.
 ALW-II-41-27 Chemical Structure
BCP26205 ALW-II-41-27 1186206-79-0
ALW-II-41-27 is a Eph receptor tyrosine kinase inhibitor.